Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes
The DOI matches its Crossref record; 55 of the 56 references it cites were found in a registry or an index.
Abstract
Transfection of embryo fibroblasts by a human ras oncogene does not convert them into tumour cells unless the fibroblasts are established and immortalized before transfection. The embryo fibroblasts become tumorigenic if a second oncogene such as a viral or cellular myc gene or the gene for the polyoma large-T antigen is introduced together with the ras gene.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, transformation of primary cells by ras requires either a cooperating oncogene or the inactivation of tumor suppressors such as p53 or p16.”
From Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a (1997) · cites this paper as Land et al. 1983
In the citing paper
“ras cooperates, however, with certain other oncogenic alterations to transform primary rodent cells (Land et al. 1983; Ruley 1983), including overexpression of c-Myc, dominant negative p53, D-type cyclins, and Cdc25A and -B, and loss of p53, p16, or IRF-1”
From Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a (1997) · cites this paper as Land et al. 1983
In the citing paper
“In that setting, dysfunctional telomeres induced a strong cellular senescence phenotype in the emerging lymphomas resulting in potent suppression of lymphomagenesis.”
From Telomeres and telomerase in cancer (2010) · cites this paper as [93]
Citations
Cites
A new technique for the assay of infectivity of human adenovirus 5 DNA
Graham, F. L., & van der Eb, A. J. (1973) · Virology · doi:10.1016/0042-6822(73)90341-3 · Cited by 9,451
Dalla-Favera, R., Bregni, M., Erikson, J., Patterson, D., Gallo, R. C., & Croce, C. M. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.24.7824 · Cited by 1,773
Mutation selection and the natural history of cancer
Cairns, J. (1975) · Nature · doi:10.1038/255197a0 · Cited by 1,582
Activation of a cellular onc gene by promoter insertion in ALV-induced lymphoid leukosis
Hayward, W. S., Neel, B. G., & Astrin, S. M. (1981) · Nature · doi:10.1038/290475a0 · Cited by 1,567
Taub, R., Kirsch, I., Morton, C., Lenoir, G., Swan, D., Tronick, S., Aaronson, S., & Leder, P. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.24.7837 · Cited by 1,422
Mechanism of activation of a human oncogene
Tabin, C. J., Bradley, S. M., Bargmann, C. I., Weinberg, R. A., Papageorge, A. G., Scolnick, E. M., Dhar, R., Lowy, D. R., & Chang, E. H. (1982) · Nature · doi:10.1038/300143a0 · Cited by 1,393
Self-citationRuley, H. E. (1983) · Nature · doi:10.1038/304602a0 · Cited by 1,248
Mulligan, R. C., & Berg, P. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.4.2072 · Cited by 982
Human EJ bladder carcinoma oncogene is homologue of Harvey sarcoma virus ras gene
Parada, L. F., Tabin, C. J., Shih, C., & Weinberg, R. A. (1982) · Nature · doi:10.1038/297474a0 · Cited by 944
Self-citationDer, C. J., Krontiris, T. G., & Cooper, G. M. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.11.3637 · Cited by 800
Research works printed but not linked: 9
- Berenblum, I. & Shubik, P. Br. J. Cancer 1, 388 (1947).
- Emmelot, P. & Scherer, E. Cancer Res. 37, 1702–1708 (1977).
- Crawford, B. D., Barrett, J. C. & Ts'o, P. O. P. Molec. cell. Biol. 3, 931–945 (1983). · doi:10.1128/mcb.3.5.931
- Murray, M. J. et al. Cell (in the press).
- Aaronson, S. A. & Todaro, G. J. J. Cell Biol. 72, 141–148 (1968).
- Perucho, M., Hanahan, D. & Wigler, M. Cell 22, 309–317 (1980). · DOI · Paper page
- Beard, J. W. in Viral Oncology (ed. Klein, G.) 55–88 (Raven, New York, 1980).
- Adams, J. M., Gerondakis, S., Webb, E., Corcoran, L. & Cory, S. Proc. natn. Acad. Sci. U.S.A. (in the press).
- Gross, L. Oncogenic viruses, 931 (Pergamon, Oxford, 1970).
Cited by
Items 401–500 of 1,010
Transformation of normal human cells in the absence of telomerase activation
Seger, Y. R., Garcı́a-Cao, M., Piccinin, S., Cunsolo, C. L., Doglioni, C., Blasco, M. A., Hannon, G. J., & Maestro, R. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00183-6 · Cited by 159
“Expression of E1A- CR2, a mutant incapacells (Land et al., 1983).”
BackgroundZerler, B., Moran, B., Maruyama, K., Moomaw, J., Grodzicker, T., & Ruley, H. E. (1986) · Molecular and Cellular Biology · doi:10.1128/mcb.6.3.887 · Cited by 160
Retrovirus vectors and their applications in neurobiology
Cepko, C. (1988) · Neuron · doi:10.1016/0896-6273(88)90184-5 · Cited by 162
Gene expression during the mammalian cell cycle
Denhardt, D. T., Edwards, D. R., & Parfett, C. L. J. (1986) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(86)90024-7 · Cited by 159
Molecular characterization of the retinoblastoma susceptibility gene
Goodrich, D. W., & Lee, W.-H. (1993) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(93)90021-4 · Cited by 159
Wodnar-Filipowicz, A., & Moroni, C. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.2.777 · Cited by 158
Taya, Y., Hosogai, K., Hirohashi, S., Shimosato, Y., Tsuchiya, R., Tsuchida, N., Fushimi, M., Sekiya, T., & Nishimura, S. (1984) · The EMBO Journal · doi:10.1002/j.1460-2075.1984.tb02236.x · Cited by 158
Cell senescence and hypermitogenic arrest
Blagosklonny, M. V. (2003) · The EMBO Reports · doi:10.1038/sj.embor.embor806 · Cited by 156
“Finally, oncogenes that act downstream of the restriction point (such as c-Myc and CDK4), and thus may overcome senescence, cooperate with hypermitogenic oncogenes (such as Ras), leading to malignant transformation (Land et al., 1983).”
BackgroundConstruction of a Novel Oncogene Based on Synthetic Sequences Encoding Epidermal Growth Factor
Stern, D. F., Hare, D. L., Cecchini, M. A., & Weinberg, R. A. (1987) · Science · doi:10.1126/science.3492043 · Cited by 155
Self-citationModelling cancer in human skin tissue
Khavari, P. A. (2006) · Nature reviews. Cancer · doi:10.1038/nrc1838 · Cited by 176
“For example, the first studies of cellular transformation focused largely on murine fibroblast”
BackgroundIdentification of c-myc as a Down-stream Target for Pituitary Tumor-transforming Gene
Pei, L. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009654200 · Cited by 154
Rettig, W. J., Spengler, B. A., Chesa, P. G., Old, L. J., & Biedler, J. L. (1987) · PubMed · Cited by 154
Yamamura, S., Saini, S., Majid, S., Hirata, H., Ueno, K., Deng, G., & Dahiya, R. (2012) · PLoS ONE · doi:10.1371/journal.pone.0029722 · Cited by 152
“Although cMyc alone is not able to transform cells and requires a co-operating oncogene such as ras oncogene [45], c-Myc is an important factor in tumor development.”
BackgroundInflammatory signaling and cellular senescence
Ren, J.-L., Pan, J.-S., Lu, Y.-P., Sun, P., & Han, J. (2009) · Cellular Signalling · doi:10.1016/j.cellsig.2008.10.011 · Cited by 148
Gotoh, N., Toyoda, M., & Shibuya, M. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.4.1824 · Cited by 153
“This is reminiscent of the previous observation that the v-ras and c-myc oncogenes cooperatively transform rat embryo fibroblasts (32).”
BackgroundResultHuman cancer and cellular oncogenes
Nishimura, S., & Sekiya, T. (1987) · Biochemical Journal · doi:10.1042/bj2430313 · Cited by 163
Müller, R. (1986) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(86)90003-x · Cited by 161
Oncogene- and tumor suppressor gene-mediated suppression of cellular senescence
Larsson, L. (2011) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2011.10.005 · Cited by 175
“viruses such as SV40-virus large T, adenovirus E1A and human papilloma virus (HPV) E7cooperate with activated Ras and similar oncogenes in transformation of primary cells [37].”
BackgroundTelomerase and human tumorigenesis
Stewart, S. A., & Weinberg, R. A. (2000) · Seminars in Cancer Biology · doi:10.1006/scbi.2000.0339 · Cited by 170
Self-citationHuman Growth Hormone-regulated HOXA1 Is a Human Mammary Epithelial Oncogene
Zhang, X., Zhu, T., Chen, Y., Mertani, H. C., Lee, K.-O., & Lobie, P. E. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212050200 · Cited by 150
Tumorigenic and metastatic properties of "normal" and ras-transfected NIH/3T3 cells.
GREIG, R. G., Koestler, T. P., Trainer, D. L., Corwin, S., Miles, L., Kline, T., Sweet, R. W., Yokoyama, S., & Poste, G. H. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.11.3698 · Cited by 152
Stern, D. F., Roberts, A. B., Roche, N. S., Sporn, M. B., & Weinberg, R. A. (1986) · Molecular and Cellular Biology · doi:10.1128/mcb.6.3.870 · Cited by 154
Self-citationImmune recognition of self in immunity against cancer
Houghton, A. N., & Guevara-Patino, J. A. (2004) · Journal of Clinical Investigation · doi:10.1172/jci22685 · Cited by 150
“T cell–dependent immunity against mutated self antigens on tumors Can cancer cells with mutated self peptides stimulate host T cells? As few as two or three distinct mutations in different cellular protooncogenes can induce malignant transformation and tumorigenicity of normal rodent cells (3, 4).”
BackgroundInhibitors of mutagenesis and their relevance to carcinogenesis
Ramel, C., Alekperov, U. K., Ames, B. N., Kada, T., & Wattenberg, L. W. (1986) · Mutation Research/Reviews in Genetic Toxicology · doi:10.1016/0165-1110(86)90021-7 · Cited by 150
Immortalization Of Neural Cells Via Retrovirus-Mediated Oncogene Transduction
Cepko, C. L. (1989) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.12.030189.000403 · Cited by 150
Carcinogenesis Modeling: From Molecular Biology to Epidemiology
Moolgavkar, S. H. (1986) · Annual Review of Public Health · doi:10.1146/annurev.pu.07.050186.001055 · Cited by 148
Transforming but not immortalizing oncogenes activate the transcription factor PEA1.
Wasylyk, C., Imler, J., & Wasylyk, B. (1988) · The EMBO Journal · doi:10.1002/j.1460-2075.1988.tb03094.x · Cited by 158
Telomeres, telomerase, and myc. An update
Cerni, C. (2000) · Mutation Research/Reviews in Mutation Research · doi:10.1016/s1383-5742(99)00091-5 · Cited by 162
Elevated c-myc protooncogene expression in autosomal recessive polycystic kidney disease.
Cowley, B. D., Smardo, F. L., Grantham, J. J., & Calvet, J. P. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.23.8394 · Cited by 147
Mandal, P. K., Schneider, M., Kölle, P., Kuhlencordt, P., Förster, H., Beck, H., Bornkamm, G. W., & Conrad, M. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1509 · Cited by 145
Possible function of the c‐myc product: promotion of cellular DNA replication.
Iguchi-Ariga, S. M., Itani, T., Kiji, Y., & Ariga, H. (1987) · The EMBO Journal · doi:10.1002/j.1460-2075.1987.tb02513.x · Cited by 147
RAS mutations in human cancers: Roles in precision medicine
Murugan, A. K., Grieco, M., & Tsuchida, N. (2019) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.06.007 · Cited by 146
Cory, S., Vaux, D. L., Strasser, A., Harris, A. W., & Adams, J. M. (1999) · PubMed · Cited by 171
Immortalization of mouse neural precursor cells by the c-myc oncogene.
Bartlett, P. F., Reid, H. H., Bailey, K. A., & Bernard, O. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.9.3255 · Cited by 146
Pater, M. M., Hughes, G. A., Hyslop, D. E., Nakshatri, H., & Pater, A. (1988) · Nature · doi:10.1038/335832a0 · Cited by 158
In vitro transformation of human epithelial cells
Chang, S. E. (1986) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(86)90001-6 · Cited by 146
Hann, S. R., Dixit, M., Sears, R. C., & Sealy, L. (1994) · Genes & Development · doi:10.1101/gad.8.20.2441 · Cited by 140
Kacinski, B. M., Carter, D., Mittal, K., Yee, L. D., Scata, K. A., DONOFRIO, L. M., Chambers, S. K., Wang, K. I., Yang‐Feng, T. L., & Rohrschneider, L. R. (1990) · Europe PMC (PubMed Central) · Cited by 145
The role of the H-ras oncogene in radiation resistance and metastasis
McKenna, W. G., Weiss, M. C., Bakanauskas, V. J., Sandler, H. M., Kelsten, M. L., Biaglow, J. E., Tuttle, S. W., Endlich, B., Ling, C. C., & Muschel, R. J. (1990) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(90)90407-b · Cited by 151
Fukuyama, Y., Mitsudomi, T., Sugio, K., Ishida, T., Akazawa, K., & Sugimachi, K. (1997) · British Journal of Cancer · doi:10.1038/bjc.1997.194 · Cited by 144
Bird, J., Galili, N., Link, M. P., Stites, D., & Sklar, J. (1988) · The Journal of Experimental Medicine · doi:10.1084/jem.168.1.229 · Cited by 145
v-erbA cooperates with sarcoma oncogenes in leukemic cell transformation
Kahn, P., Frykberg, L., Brady, C., Stanley, I., Beug, H., Vennström, B., & Graf, T. (1986) · Cell · doi:10.1016/0092-8674(86)90320-x · Cited by 156
SV40: Cell transformation and tumorigenesis
Pipas, J. M. (2009) · Virology · doi:10.1016/j.virol.2008.11.024 · Cited by 140
“Similarly, different cellular oncogenes cooperate to transform cells (Land et al., 1983; Ruley, 1983).”
BackgroundRole of Telomeres and Telomerase in the Pathogenesis of Human Cancer
Hahn, W. C. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.06.018 · Cited by 143
Hateboer, G., Timmers, H. T. M., Rustgi, A., Billaud, M., Veer, L. V. ‘., & Bernards, R. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.18.8489 · Cited by 142
Resistance of human cells to tumorigenesis induced by cloned transforming genes.
Sager, R., Tanaka, K., Lau, C. C., Ebina, Y., & Anisowicz, A. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.24.7601 · Cited by 143
Isolation of the proto-oncogene c-myb from D. melanogaster
Katzen, A. L., Kornberg, T. B., & Bishop, J. M. (1985) · Cell · doi:10.1016/s0092-8674(85)80018-0 · Cited by 142
The release of growth arrest by microinjection of adenovirus E1A DNA.
Stabel, S., Argos, P., & Philipson, L. (1985) · The EMBO Journal · doi:10.1002/j.1460-2075.1985.tb03934.x · Cited by 142
Interferon regulates c-myc gene expression in Daudi cells at the post-transcriptional level.
Knight, E., Anton, E. D., Fahey, D., Friedland, B. K., & Jonak, G. J. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.4.1151 · Cited by 142
Vial, E., & Marshall, C. J. (2003) · Journal of Cell Science · doi:10.1242/jcs.00812 · Cited by 138
“All the Fos family members display oncogenic activities (Bergers et al., 1995; Miller et al., 1984; Nishina et al., 1990; Schuermann et al., 1991); however, the requirement for c-Fos in Rasmediated transformation is not clear (Hu et al., 1994; Ledwith et al., 1990; Saez et al., 1995).”
Backgroundp19 Arf induces p53-dependent apoptosis during Abelson virus-mediated pre-B cell transformation
Radfar, A., Unnikrishnan, I., Lee, H.-W., DePinho, R. A., & Rosenberg, N. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.22.13194 · Cited by 138
Transcriptional Activation of Mammalian Ornithine Decarboxylase During Stimulated Growth
Katz, A., & Kahana, C. (1987) · Molecular and Cellular Biology · doi:10.1128/mcb.7.7.2641 · Cited by 140
Morice, W. G., Wiederrecht, G., Brunn, G. J., Siekierka, J. J., & Abraham, R. T. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)41589-x · Cited by 140
Boiko, A. D., Porteous, S., Razorenova, O. V., Krivokrysenko, V. I., Williams, B. R. G., & Gudkov, A. V. (2006) · Genes & Development · doi:10.1101/gad.1372606 · Cited by 152
“This concept, originally based on the studies of primary rodent fibroblasts transformed by the combination of oncogenes Ras and Myc (Land et al. 1983; Ruley 1983), which were thought to induce transformation and immortalization, respectively, was then extended to several combinations of genetic events, some of which a…”
BackgroundInfluentialThe Cat and Mouse Games That Genes, Viruses, and Cells Play
Weinberg, R. A. (1997) · Cell · doi:10.1016/s0092-8674(00)81897-8 · Cited by 138
Self-citationmyc oncogenes: activation and amplification
Alitalo, K. K., Koskinen, P. J., Mäkelä, T. P., Saksela, K., Sistonen, L., & Winqvist, R. (1987) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(87)90016-3 · Cited by 149
TRRAP-Dependent and TRRAP-Independent Transcriptional Activation by Myc Family Oncoproteins
Nikiforov, M. A., Chandriani, S., Park, J., Kotenko, I., Matheos, D., Johnsson, A., McMahon, S. B., & Cole, M. D. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.14.5054-5063.2002 · Cited by 136
“, E1A(10-39)–N-MycMBII , and cannot activate TERT, i.”
BackgroundInfluentialTranscriptional repression of the neu protooncogene by the adenovirus 5 E1A gene products.
Yu, D., Suen, T.-C., Yan, D., Chang, L., & Hung, M. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.12.4499 · Cited by 142
Selective reduction of c-myc mRNA in Daudi cells by human beta interferon.
Jonak, G. J., & Knight, E. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.6.1747 · Cited by 137
The c-Myc Transactivation Domain Is a Direct Modulator of Apoptotic versus Proliferative Signals
Chang, D. W., Claassen, G. F., Hann, S. R., & Cole, M. D. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.12.4309-4319.2000 · Cited by 134
“Each c-Myc allele was assayed for oncogenic transformation of early-passage rat embryo cells in cooperation with the H-rasG12V oncogene (Fig. 1) ( 34 ).”
BackgroundChang, J., Yang, S.-H., Cho, Y.-G., Hwang, S. B., Hahn, Y. S., & Sung, Y. C. (1998) · Journal of Virology · doi:10.1128/jvi.72.4.3060-3065.1998 · Cited by 136
“However, the oncogenic activity of the core protein in our study was not strong enough for the protein to readily transform primary REFs in cooperation with H-ras, compared with other immortalizing oncogenes such as E1A, c-myc, and human papillomavirus 16 E6, or E7 (3, 12, 13, 26, 30, 33).”
BackgroundMethodEndothelial cell tumors develop in transgenic mice carrying polyoma virus middle T oncogene
Bautch, V. L., Toda, S., Hassell, J. A., & Hanahan, D. (1987) · Cell · doi:10.1016/0092-8674(87)90122-x · Cited by 136
Glycolysis and methylaminoisobutyrate uptake in rat-1 cells transfected with ras or myc oncogenes.
Racker, E., Resnick, R. J., & Feldman, R. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.11.3535 · Cited by 135
Yee, A. S., Reichel, R. R., Kovesdi, I., & Nevins, J. R. (1987) · The EMBO Journal · doi:10.1002/j.1460-2075.1987.tb02471.x · Cited by 152
FoxO transcription factors suppress Myc-driven lymphomagenesis via direct activation of Arf
Bouchard, C., Lee, S., Paulus-Hock, V., Loddenkemper, C., Eilers, M., & Schmitt, C. A. (2007) · Genes & Development · doi:10.1101/gad.453107 · Cited by 126
“In support of this view, we recently identified Akt-mediated phosphorylation of FoxO proteins as the critical PI3-kinase signaling component that substitutes for oncogenic Ras in Myc-induced proliferation and focus formation in vitro (Land et al. 1983; Bouchard et al. 2004).”
BackgroundLoss of p16 pathways stabilizes EWS/FLI1 expression and complements EWS/FLI1 mediated transformation
Deneen, B., & Denny, C. T. (2001) · Oncogene · doi:10.1038/sj.onc.1204875 · Cited by 144
“However when co-expressed with a cooperating oncogene such as c-MYC or in a cellular environment de®cient in key tumor suppressors such as p53 or p16, RAS is able to promote cellular transformation (Land et al., 1983; Serrano et al., 1997).”
BackgroundCritical Role for SV40 Small-t Antigen in Human Cell Transformation
Yu, J., Boyapati, A., & Rundell, K. (2001) · Virology · doi:10.1006/viro.2001.1204 · Cited by 134
Peters, G. G., Lee, A. E., & Dickson, C. (1986) · Nature · doi:10.1038/320628a0 · Cited by 134
Vitale-Cross, L., Amornphimoltham, P., Fisher, G., Molinolo, A. A., & Gutkind, J. S. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-2623 · Cited by 129
“considered insufficient to directly promote carcinogenesis (16).”
Perspectives on clonogenic tumor cells, stem cells, and oncogenes.
Buick, R. N., & Pollak, M. (1984) · PubMed · Cited by 142
Effect of cell spreading on cytoplasmic pH in normal and transformed fibroblasts.
Schwartz, M. A., Both, G., & Lechène, C. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.12.4525 · Cited by 133
Cohen, J. B., & Levinson, A. D. (1988) · Nature · doi:10.1038/334119a0 · Cited by 153
Activation and repression of mammalian gene expression by the c-myc protein.Preprint
Kaddurah‐Daouk, R., Greene, J. M., Baldwin, A. S., & Kingston, R. E. (1987) · Genes & Development · doi:10.1101/gad.1.4.347 · Cited by 133
Lü, X., Park, S. H., Thompson, T. C., & Lane, D. P. (1992) · Cell · doi:10.1016/0092-8674(92)90541-j · Cited by 132
McKenna, W. G., Iliakis, G. E., Weiss, M. C., Bernhard, E. J., & Muschel, R. J. (1991) · Radiation Research · doi:10.2307/3578111 · Cited by 132
A novel function of the transforming domain of E1a: Repression of AP-1 activity
Offringa, R., Gebel, S., van Dam, H., Timmers, H. T. M., de Vries-Smits, A. M. M., Zwart, R., Stein, B., Bos, J. L., van der Eb, A. J., & Herrlich, P. A. (1990) · Cell · doi:10.1016/0092-8674(90)90017-9 · Cited by 139
Trosko, J. E., & Chang, C. (2001) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/s0027-5107(01)00181-6 · Cited by 131
Falcone, G., Tatò, F., & Alemà, S. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.2.426 · Cited by 131
Kumar, M., Seeger, W., & Voswinckel, R. (2014) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2013-0382ps · Cited by 127
“Oncogene-Induced Premature Senescence In Vitro Transfection of GTPase HRas, also known as transforming protein p21 or HRAS, can induce cell cycle arrest in primary cells (31).”
BackgroundInducible overproduction of the mouse c-myc protein in mammalian cells.
Wurm, F. M., Gwinn, K. A., & Kingston, R. E. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.15.5414 · Cited by 133
Defining a role for c-Myc in breast tumorigenesis
Nass, S. J., & Dickson, R. B. (1997) · Breast Cancer Research and Treatment · doi:10.1023/a:1005858611585 · Cited by 130
Mechanisms and functions of Nrf2 signaling in Drosophila
Pitoniak, A., & Bohmann, D. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.06.020 · Cited by 140
“Deregulation of Myc is observed in a large number of different cancer types and is considered a classic oncogenic event (Dang, 2012; Land et al., 1983).”
Role of RAS in the Regulation of PI 3-Kinase
Castellano, E., & Downward, J. (2010) · Current topics in microbiology and immunology · doi:10.1007/82_2010_56 · Cited by 149
Immortalisation and transformation revisited
Drayton, S., & Peters, G. (2002) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(01)00271-4 · Cited by 153
Cleveland, J. L., Dean, M. C., Rosenberg, N. E., Wang, J. Y. J., & Rapp, U. R. (1989) · Molecular and Cellular Biology · doi:10.1128/mcb.9.12.5685 · Cited by 129
Activated oncogenes promote and cooperate with chromosomal instability for neoplastic transformation
Woo, R. A., & Poon, R. Y. C. (2004) · Genes & Development · doi:10.1101/gad.1165204 · Cited by 124
“The chromosomal instability caused by HRasV12 could be rescued by treating the cells with Nacetyl-cysteine (NAC; Lee et al. 1999), a precursor of reduced glutathione and a scavenger of reactive oxygen species (ROS; Aruoma et al. 1989; Burgunder et al. 1989).”
BackgroundMethodInfluentialAntiproliferative properties of the USF family of helix-loop-helix transcription factors.
Luo, X., & Sawadogo, M. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.3.1308 · Cited by 128
Kwan, H. C. K., Pečenka, V., Tsukamoto, A. S., Parslow, T. G., Guzman, R., Lin, T. P., Muller, W. J., Lee, F. S., Leder, P., & VARMUS, H. E. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.1.147 · Cited by 135
Dynamic Expression Pattern of the myc Protooncogene in Midgestation Mouse Embryos
Schmid, P., Schulz, W. A., & Hameister, H. (1989) · Science · doi:10.1126/science.2911736 · Cited by 128
Multiple Mechanisms for Transcriptional Regulation of the myc Gene Family in Small-Cell Lung Cancer
Krystal, G., Birrer, M. J., Way, J., Nau, M. M., Sausville, E. A., Thompson, C., Minna, J. D., & Battey, J. F. (1988) · Molecular and Cellular Biology · doi:10.1128/mcb.8.8.3373 · Cited by 128
Zauli, G., Gibellini, D., Milani, D., Mazzoni, M., Borgatti, P., Plaça, M. L., & Capitani, S. (1993) · PubMed · Cited by 128
Smooth muscle α-actin is a transformation-sensitive marker for mouse NIH 3T3 and Rat-2 cells
Leavitt, J. C., Gunning, P. W., Kedes, L., & Jariwalla, R. J. (1985) · Nature · doi:10.1038/316840a0 · Cited by 128
Edelman, L. B., Eddy, J. A., & Price, N. D. (2010) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.75 · Cited by 153
“At the molecular level, genetic lesions interact synergistically to evade tumor suppression pathways, with no single mutation typically sufficient to cause transformation [2–6].”
BackgroundMaxwell, I. H., Maxwell, F., & Glode, L. M. (1986) · PubMed · Cited by 127
Zhu, J., Abate, M., Rice, P. W., & Cole, C. N. (1991) · Journal of Virology · doi:10.1128/jvi.65.12.6872-6880.1991 · Cited by 145
Myc-mediated transformation: the repression connection
Claassen, G. F., & Hann, S. (1999) · Oncogene · doi:10.1038/sj.onc.1202747 · Cited by 128
“Myc requires expression of a second oncogene, such as activated ras for the transformation of most cell types, including REFs (Land et al., 1983; Ruley, 1990).”
Backgroundc-MYC-Induced Genomic Instability
Kuzyk, A., & Mai, S. (2014) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a014373 · Cited by 124
“Early studies implicated MYC in cell proliferation (Palmieri et al. 1983), but it was insufficient for cellular transformation unless it cooperated with a second oncogene, RAS, to transform primary embryo fibroblasts (Land et al. 1983, 1986).”
BackgroundHonda, M., Kaneko, S., Shimazaki, T., Matsushita, E., Kobayashi, K., Ping, L., Zhang, H.-C., & Lemon, S. M. (2000) · Hepatology · doi:10.1053/jhep.2000.7985 · Cited by 127
Santoro, M., Melillo, R. M., Grieco, M., Berlingieri, M. T., Vecchio, G., & Fusco, A. (1993) · PubMed · Cited by 145
Meroni, G., Reymond, A., Alcalay, M., Borsani, G., Tanigami, A., Tonlorenzi, R., Nigro, C. L., Messali, S., Zollo, M., Ledbetter, D. H., et al. (1997) · The EMBO Journal · doi:10.1093/emboj/16.10.2892 · Cited by 143
“…cow, cat, dog, chicken, rabbit, mouse, hamster and Drosophila).transform primary rat embryo fibroblasts in association with the c-Ha-ras oncogene (Land et al., 1983; Schwab Hybridization bands were observed in the lanes corres- ponding to all species tested, indicating a high degree ofet al.,…”
Background
Metadata
- Authors
- Land, H., Parada, L. F., & Weinberg, R. A.
- Affiliations
- Whitehead Institute for Biomedical Research (US)
- Venue
- Nature
- Published
- 1983-08
- Volume
- 304
- Issue
- 5927
- Pages
- 596-602
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1989009382
- Cited by
- 2,804
- References
- 56
- Citations by year
- 2026: 8 · 2025: 13 · 2024: 22 · 2023: 15 · 2022: 17 · 2021: 24 · 2020: 22 · 2019: 36 · 2018: 17 · 2017: 23 · 2016: 24 · 2015: 39 · 2014: 27 · 2013: 30 · 2012: 37
- FWCI
- 96.77
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and Retrovirus Studies
- Keywords
- embryonic fibroblasts, oncogene cooperation, oncogenic Ras, MYC gene, polyomavirus large T antigen, cell immortalization, transfection
- MeSH terms
- Animals, Antigens, Viral, Antigens, Viral, Tumor, Cell Line, Cell Transformation, Viral, Cells, Cultured, Fibroblasts, Gene Expression Regulation, Genes, Viral, Genetic Complementation Test, Oncogenes, Phenotype, Polyomavirus, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.